Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 3554Sesión 89R

Qué cambió entre versiones

2 párrafos cambiaron+6 palabras agregadas−2 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

89R13770 MPF-D

By: Simmons

By: Simmons, Lalani, Oliverson, Howard, Rose

H.B. No. 3554

150 párrafos sin cambios

A BILL TO BE ENTITLED

AN ACT

relating to establishment of the Texas Rare Disease Advisory

Council.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subtitle E, Title 2, Health and Safety Code, is

amended by adding Chapter 101A to read as follows:

CHAPTER 101A. TEXAS RARE DISEASE ADVISORY COUNCIL

Sec. 101A.001. DEFINITIONS. In this chapter:

(1) "Advisory council" means the Texas Rare Disease

Advisory Council established under this chapter.

(2) "Rare disease" means a disease, disorder, or

condition that affects fewer than 200,000 individuals in the United

States.

Sec. 101A.002. ESTABLISHMENT. (a) The Texas Rare Disease

Advisory Council is established to advise the governor, state

agencies, and private entities that provide health care services or

other treatment to individuals diagnosed with rare diseases in this

state on strategies for improving health outcomes for those

individuals.

(b) The department shall provide to the advisory council

resources, personnel, and other administrative support as

necessary for the council to carry out its duties under this

chapter.

Sec. 101A.003. ADVISORY COUNCIL MEMBERS. (a) The advisory

council is composed of 23 members appointed as follows:

(1) 11 members appointed by the governor as follows:

(A) one representative of the department;

(B) one representative of the commission;

(C) one representative of the Texas Department of

Insurance;

(D) one representative of the Texas Education

Agency;

(E) one geneticist practicing in this state;

(F) one registered nurse or advanced practice

registered nurse licensed and practicing in this state with

experience in treating rare diseases;

(G) one hospital administrator of a hospital in

this state that provides care to individuals diagnosed with a rare

disease;

(H) one pharmacist licensed and practicing in

this state with experience dispensing prescription drugs used in

treating rare diseases;

(I) one representative of the biotechnology

industry;

(J) one representative of a health insurance

company; and

(K) one physician licensed and practicing in this

state with experience in treating rare diseases;

(2) six members appointed by the lieutenant governor

as follows:

(A) one representative of an academic research

institution in this state that receives grant funding for rare

disease research;

(B) one physician licensed and practicing in this

state with experience in treating rare diseases;

(C) one individual who is 18 years of age or older

and who is diagnosed with a rare disease;

(D) two individuals who are, or previously served

as, caregivers for an individual diagnosed with a rare disease; and

(E) one representative of an organization that

provides care or other support to individuals diagnosed with a rare

disease in this state; and

(3) six members appointed by the speaker of the house

of representatives as follows:

(A) one representative of an academic research

institution in this state that receives grant funding for rare

disease research;

(B) one physician licensed and practicing in this

state with experience in treating rare diseases;

(C) one individual who is 18 years of age or older

and who is diagnosed with a rare disease;

(D) two individuals who are, or previously served

as, caregivers for an individual diagnosed with a rare disease; and

(E) one representative of an organization that

provides care or other support to individuals diagnosed with a rare

disease in this state.

(b) Advisory council members serve staggered four-year

terms, with the terms of one-half of the members, or as near to

one-half as possible, expiring February 1 of each odd-numbered

year.

(c) A vacancy on the advisory council shall be filled for

the unexpired term in the same manner as the original appointment.

Sec. 101A.004. PRESIDING OFFICER; ASSISTANT PRESIDING

OFFICER. The governor shall annually select from among the

advisory council members a presiding officer and an assistant

presiding officer.

Sec. 101A.005. COUNCIL MEETINGS. (a) The advisory council

shall meet:

(1) at the call of the advisory council's presiding

officer; and

(2) on request by a majority of the advisory council

members.

(b) A majority of the voting members of the advisory council

constitutes a quorum.

(c) A meeting conducted under this section may be in person

or by video conference call, as determined by the advisory

council's presiding officer.

(d) The advisory council shall provide notice of upcoming

advisory council meetings on the department's Internet website.

Sec. 101A.006. DUTIES. (a) The advisory council shall:

(1) consult with experts on rare diseases and solicit

public comment to develop policy recommendations for improving the

treatment of rare diseases in this state;

(2) develop strategy recommendations for academic

research institutions of higher education in this state to

facilitate continued research on rare diseases;

(3) develop strategy recommendations for health care

providers to better recognize and diagnose rare diseases to improve

patient treatment; and

(4) make recommendations to the department and other

state agencies on matters affecting individuals diagnosed with a

rare disease, including emergency preparedness and response

resources for a pandemic or natural disaster.

(b) The advisory council shall provide the department with

the strategy recommendations developed under Subsection (a)(3) for

publication on the department's Internet website.

Sec. 101A.007. ANNUAL REPORT. (a) Not later than September

1 of each year, the advisory council shall prepare and submit to the

governor and commissioner a report that includes:

(1) a summary of the advisory council's activities for

the preceding year; and

(2) recommendations for legislative or other action on

rare disease research and care.

(b) The advisory council shall publish the report prepared

and submitted under Subsection (a) on the department's Internet

website.

Sec. 101A.008. APPLICABILITY OF OTHER LAW. Section

2110.008, Government Code, does not apply to the advisory council.

SECTION 2. Not later than December 1, 2025, the appropriate

appointing authority shall appoint the initial members to the Texas

Rare Disease Advisory Council as required by Section 101A.003(a),

Health and Safety Code, as added by this Act, with the initial

members' terms expiring as follows:

(1) the terms of five members appointed under Section

101A.003(a)(1), of three members appointed under Section

101A.003(a)(2), and of three members appointed under Section

101A.003(a)(3) expiring February 1, 2029; and

(2) the terms of six members appointed under Section

101A.003(a)(1), of three members appointed under Section

101A.003(a)(2), and of three members appointed under Section

101A.003(a)(3) expiring February 1, 2031.

SECTION 3. Notwithstanding Section 101A.005, Health and

Safety Code, as added by this Act, the Texas Rare Disease Advisory

Council shall conduct the council's first meeting not later than

January 1, 2026.

SECTION 4. Notwithstanding Section 101A.007, Health and

Safety Code, as added by this Act, the Texas Rare Disease Advisory

Council shall submit the first report required by that section not

later than September 1, 2026.

SECTION 5. This Act takes effect September 1, 2025.

Volver al texto completo